Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Early Hum Dev ; 194: 106050, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38781715

ABSTRACT

BACKGROUND: Our objective was to determine whether the use of two or more courses of low-dose systemic dexamethasone for extubation of ventilator-dependent preterm infants after the first week of life, as proposed in the DART study, is associated with greater neurodevelopmental harm at two years of corrected age, compared to a single course. METHODS: Retrospective review at seven level III neonatal intensive care units. Preterm infants who underwent only one course of systemic dexamethasone for extubation were grouped into DART-1; those who underwent two or more courses were grouped into DART-2. Data and outcomes of infants in DART-2 were compared with those in DART-1. RESULTS: 150 preterm infants were studied: 104 in DART-1 and 46 in DART-2. Patients in DART-2 had a lower gestational age (25 vs. 26 weeks, p = 0.031) and greater morbidity. The average dexamethasone cumulative dose for patients in DART-1 was 0.819 mg/kg, vs. 1.697 mg/kg for patients in DART-2. A total of 14 patients died. The neuromotor and neurosensory assessments at two years of corrected age revealed in the DART-2 survivors, after the multivariate analysis, a higher prevalence of cerebral palsy with functional motor class 2 (OR = 6.837; 95%CI: 1.054-44.337; p = 0.044) and ophthalmological problems requiring the use of glasses (OR = 4.157; 95%CI: 1.026-16.837; p = 0.046). CONCLUSIONS: In this cohort, the use of more than one course of systemic dexamethasone in low doses for extubation of ventilator-dependent premature infants after the first week of life was associated, at two years of corrected age, with a higher prevalence of cerebral palsy with functional motor class 2 and ophthalmological problems requiring the use of glasses.


Subject(s)
Cerebral Palsy , Dexamethasone , Infant, Premature , Humans , Dexamethasone/administration & dosage , Dexamethasone/adverse effects , Cerebral Palsy/epidemiology , Infant, Newborn , Female , Male , Retrospective Studies , Child, Preschool , Prevalence , Airway Extubation , Respiration, Artificial
2.
Am J Perinatol ; 36(2): 176-183, 2019 01.
Article in English | MEDLINE | ID: mdl-29996153

ABSTRACT

INTRODUCTION: It is not yet fully known whether hypertensive disorders (HTD) during pregnancy impose an increased risk of development of bronchopulmonary dysplasia (BPD) in preterm newborn infants. OBJECTIVE: To test the hypothesis that preeclampsia and other HTD are associated with the development of BPD in preterm infants. MATERIALS AND METHODS: Data on mothers and preterm infants with gestational age 24 to 30 weeks were prospectively analyzed in 11 Portuguese level III centers. Statistical analysis was performed using IBM SPSS statistics 23. RESULTS: A total of 494 preterm infants from 410 mothers were enrolled, and 119 (28%) of the 425 babies, still alive at 36 weeks, developed BPD. The association between chronic arterial hypertension, chronic arterial hypertension with superimposed preeclampsia, and gestational hypertension in mothers and BPD in preterm infants was not significant (p = 0.115; p = 0.248; p = 0.060, respectively). The association between preeclampsia-eclampsia and BPD was significant (p = 0.007). The multivariate analysis revealed an association between preeclampsia-eclampsia and BPD (odds ratio [OR] = 4.6; 95% confidence interval [CI] 1.529-13.819; p = 0.007) and a protective effect for BPD when preeclampsia occurred superimposed on chronic arterial hypertension in mothers (OR = 0.077; 95%CI 0.009-0.632; p = 0.017). CONCLUSION: The results of this study support the association of preeclampsia in mothers with BPD in preterm babies and suggest that chronic hypertension may be protective for preterm babies.


Subject(s)
Bronchopulmonary Dysplasia/etiology , Hypertension, Pregnancy-Induced , Pre-Eclampsia , Adult , Birth Weight , Female , Humans , Infant, Extremely Premature , Infant, Newborn , Infant, Newborn, Diseases/mortality , Infant, Premature , Logistic Models , Pregnancy , Prospective Studies , Risk Factors
3.
4.
J Perinatol ; 38(9): 1165-1173, 2018 09.
Article in English | MEDLINE | ID: mdl-29808003

ABSTRACT

INTRODUCTION: It is not known whether very preterm infants born to preeclamptic women have worse outcomes than those delivered preterm for other causes. OBJECTIVE: We assessed the association between preeclampsia (PE) and the neonatal morbidity and mortality of very preterm infants. METHODS: Over 2015 and 2016, 11 collaborating Portuguese level III NICUs prospectively enrolled a cohort of mothers with or without PE who delivered liveborn premature infants between 24 and 30 completed weeks of gestation. Data on neonatal morbidities were collected and their association to PE was assessed. RESULTS: The final cohort consisted of 410 mothers who delivered 494 preterm infants. Infants from PE mothers weighed less than those of non-PE mothers (819 ± 207 g vs. 989 ± 256 g, p < 0.0001). Incidences of respiratory distress syndrome, patent ductus arteriosus, early and nosocomial sepsis, necrotizing enterocolitis, pneumonia, meningitis, retinopathy of prematurity, intraventricular hemorrhage, periventricular infarction, periventricular leukomalacia, and mortality did not differ significantly between infants of PE or non-PE mothers. Incidence of bronchopulmonary dysplasia (BPD-defined as oxygen dependency at 36 weeks) was higher in PE infants compared with non-PE infants by both univariate and multivariate logistic regression (p = 0.007). CONCLUSION: We conclude that, when controlling for gestational age, maternal PE results in higher incidence of only BPD among preterm Portuguese infants.


Subject(s)
Bronchopulmonary Dysplasia/epidemiology , Infant, Premature, Diseases/epidemiology , Pre-Eclampsia/epidemiology , Adult , Female , Gestational Age , Humans , Incidence , Infant , Infant Mortality , Infant, Extremely Premature , Infant, Newborn , Logistic Models , Male , Multivariate Analysis , Portugal/epidemiology , Pregnancy , Prognosis , Prospective Studies
5.
Int J Pediatr Otorhinolaryngol ; 79(2): 175-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25554574

ABSTRACT

OBJECTIVE: The need for culturally appropriate and linguistically accessible instruments for assessing sleep quality among children has expanded. The Pediatric Sleep Questionnaire (PSQ) is a validated tool for sleep disordered breathing among children. Our aim was to cross-culturally translate and adapt the PSQ into Portuguese language for use in clinical and research settings. METHODS: The PSQ was translated into Portuguese language in accordance with the stages recommended by International Guidelines and reviewed by a panel of experts. The caregivers of 180 children (aged from 4 to 12 years) answered the Portuguese version of PSQ. The reliability of the translated questionnaire was measured by Cronbach α, Pearson correlation and Kappa statistics. RESULTS: Reliability analysis yielded an overall Cronbach α of 0.781, confirming the survey's consistency. The Cronbach α of the Portuguese PSQ domains ranged between 0.61 and 0.7. Test-retest reliability for all items was robust with correctness of >90.0% in all items, and the Kappa statistic ranged between 0.5 and 0.8. CONCLUSION: The Portuguese version of PSQ has sufficient reliability and validity to measure sleep disordered breathing outcomes, and showed to be linguistically accurate and acceptable for use by children in Portugal.


Subject(s)
Sleep Apnea Syndromes/diagnosis , Surveys and Questionnaires , Child , Child, Preschool , Culture , Female , Humans , Male , Portugal , Reproducibility of Results , Translating
SELECTION OF CITATIONS
SEARCH DETAIL
...